Healthcare
Warby Parker Inc.(WRBY)
Live Price
Offline$25.96
+7.18% today
1Y Change
+10.34%
Window
Jun 23, 2025 โ Jun 17, 2026
- Market Cap
- $2.70B
- Revenue Growth
- +13.0%
- EPS Growth
- +107.9%
- Dividend Yield
- 0.0%
Coverage: 248 bars ยท Jun 23, 2025 โ Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Warby Parker Inc. (WRBY) is a Healthcare stock with a market cap of $2.70B and listed on NYSE. The stock last traded around $25.96 and up 10.3% across the available one-year price window (Jun 23, 2025 โ Jun 17, 2026). Baseline metrics include revenue growth of +13.0%, EPS growth of +107.9%, a dividend yield of 0.0%. What stands out right now is revenue +13.0%, EPS +107.9%, free cash flow +26.0% with operating margin -0.6% and ROIC -0.5%. Valuation already assumes a fairly strong business story at P/E 1650.8 and price/sales 3.1. Stock Foundry combines WRBY price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+13.0% vs +7.6% peer median
Operating Margin
Below sector median
-0.6% vs +19.4% peer median
P/E
Above sector median
1650.8 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 14, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +13.0% and EPS at +107.9%, with operating margin around -0.6%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -2.8% over the next 5 trading days and finished higher after 2 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 14, 2026 | โ | -0.6% | -15.2% | -8.4% |
2026 Feb 26, 2026 | -180.0% | -2.5% | +4.8% | -14.3% |
2025 Nov 6, 2025 | +22.2% | +1.7% | +2.1% | +10.9% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
WRBY
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
WRBY Max Drawdown
-42.26%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for WRBY and SPY.
Company Overview
Warby Parker Inc.
New York Stock Exchange
Warby Parker Inc. provides eyewear products. It offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, and contact lenses, as well as accessories, including cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray. The company also offers eye exams and vision tests directly to consumers through its retail stores, website, and mobile apps. As of May 16, 2022, it had 160 retail stores in the United States and Canada. The company was formerly known as JAND, Inc. and changed its name to Warby Parker Inc. in June 2021. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.
- Leadership
- Neil Harris Blumenthal
- IPO Date
- Sep 29, 2021
- Employees
- 2.2k
- Street Address
- 233 Spring Street
- Mailing
- New York City, NY, 10013
- Region
- New York City, NY, US
- Reporting Currency
- USD
- Investor Line
- 646 847 7215
- Last Updated
- May 6, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 1650.8
- EV/EBITDA
- 54.1
- Price/Sales
- 3.1
- Price/Book
- 7.4
Growth
- Revenue
- +13.0%
- EPS
- +107.9%
- Free Cash Flow
- +26.0%
Profitability
- Gross Margin
- 54.0%
- Operating Margin
- -0.6%
- Net Margin
- 0.2%
- ROE
- 0.5%
- ROIC
- -0.5%
Balance Sheet
- Debt/Equity
- 0.63
- Current Ratio
- 2.35
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.